Mitral valve replacement in a patient with idiopathic hypereosinophilic syndrome and pulmonary arterial hypertension

Journal of Cardiac Surgery
Ilker KirisSema Bircan

Abstract

Idiopathic hypereosinophilic syndrome, a rarely seen systemic disease, may cause cardiac valvular lesions by eosinophilic infiltration. This report describes management of a 25-year-old woman with idiopathic hypereosinophilic syndrome, severe mitral stenosis, and pulmonary arterial hypertension. The patient was presented with haemoptysia and dyspnea on exertion. Echocardiography showed severe mitral stenosis and pulmonary arterial hypertension. After hematological stabilization, she underwent mitral valve replacement using a No. 27 bovine pericardial valve. In the intensive care unit she had a pulmonary hypertensive crisis, which ameliorated gradually with sedation and nitroglycerin. She was extubated and discharged on the second and seventh days, respectively. Surgical experience for the patients with mitral dysfunction caused by idiopathic hypereosinophilic syndrome is limited. When mitral valve replacement is needed, the ideal type of prosthesis remains unclear and the presence of pulmonary arterial hypertension further complicates the management. We think that bioprosthetic valves would be the appropriate choice in eosinophilic mitral dysfunction requiring valve replacement.

References

Aug 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·S ArsiwalaR Firmin
Apr 2, 2002·Cardiology in the Young·Dorothy J RadfordPeter G Pohlner

❮ Previous
Next ❯

Citations

Jul 24, 2018·Pulmonary Circulation·Liping ZhangWeihua Zhang
Sep 14, 2010·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·Jennie M WaldronC M McNamara
May 4, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Erin KaltenbrunFrank L Conlon
Dec 15, 2012·American Journal of Medical Genetics. Part a·Karen W GrippJonathan Salvin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.